TITLE

Review: Pygeum africanum extracts improve symptoms and urodynamics in symptomatic benign prostatic hyperplasia

AUTHOR(S)
Barry, Michael
PUB. DATE
September 2002
SOURCE
ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p61
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that investigated the effect of African plum tree versus placebo in improving symptoms or urodynamics in men with symptomatic benign prostatic hyperplasia. Information on data sources and study selection; Comparison of overall improvement in symptoms; Weighted mean differences in peak urine flow, residual urine volume and nocturia.
ACCESSION #
7519818

 

Related Articles

  • Saw palmetto no more effective than placebo for urinary symptoms.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p164 

    The article reports on the result of a study funded by the U.S. National Institutes of Health which reveals that saw palmetto does not lessen urinary problems related to prostate enlargement than a placebo.

  • Androgen decreases osteoprotegerin expression in prostate cancer cells.  // Prostate Cancer & Prostatic Diseases;2008, Vol. 11 Issue 2, p209 

    Corrections to two articles are presented including "Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial," by M. I. Resnick et al., and "Androgen decreases osteoprotegerin expression in prostate cancer cells"

  • Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial. Resnick, M I; Roehrborn, C G // Prostate Cancer & Prostatic Diseases;2008, Vol. 11 Issue 2, p209 

    Corrections to two articles are presented including "Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial," by M. I. Resnick et al., and "Androgen decreases osteoprotegerin expression in prostate cancer cells"

  • Don't overlook impact of inflammation on BPH. Schaeffer, Anthony J. // Urology Times;5/1/2005, Vol. 33 Issue 5, p2 

    This article discusses the impact of inflammation on benign prostatic hyperplasia (BPH), and suggests that one should not overlook the impact of inflammation. A research conducted by Claus Roehrborn has shown that prostate inflammation adversely impacts outcomes in men with BPH, an intriguing...

  • Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia. Rosen, R.; Seftel, A.; Roehrborn, C. G. // International Journal of Impotence Research;Sep2007, Vol. 19 Issue 5, p480 

    We evaluated the effects of extended-release alfuzosin HCl 10 mg once daily (q.d.) on sexual function in men with lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). In a randomized, double-blind, placebo-controlled study of men aged ≥50 years, after a 28-day...

  • Doxazosin plus finasteride reduced clinical progression of benign prostatic hyperplasia more than either drug used alone. Hoffman, Richard // ACP Journal Club;Jul/Aug2004, Vol. 141 Issue 1, p20 

    Doxazosin plus finasteride reduced clinical progression of benign prostatic hyperplasia more than either drug used alone. In men with benign prostatic hyperplasia, long-term doxazosin plus finasteride combination therapy reduced the risk for overall clinical progression of benign prostatic...

  • Saw palmetto did not differ from placebo for benign prostatic hyperplasia in men.  // ACP Journal Club;Jul/Aug2006, Vol. 145 Issue 1, p12 

    The article presents information on a study which determines how saw palmetto did not vary from placebo for benign prostatic hyperplasia in men. The study is supported by the National Institute of Diabetes and Digestive and Kidney Disease and the National Center for Complementary and Alternative...

  • Saw palmetto extracts for benign prostatic hyperplasia. Segars, Larry W. // Journal of Family Practice;Feb1999, Vol. 48 Issue 2, p88 

    The article examines whether saw palmetto extracts are effective for the treatment of benign prostatic hypertrophy (BPH). Symptoms associated with BPH are common in elderly men and can include urgency, frequency, hesitancy, weak stream, and incomplete voiding. The authors review available data...

  • TERAZOSIN VS FINASTERIDE FOR BPH. Zacks, Michael // Journal of Family Practice;Dec1996, Vol. 43 Issue 6, p533 

    The article presents a Comparison of terazosin, finasteride and combination therapy in the treatment of benign prostatic hypertrophy (BPH). Men aged 45 to 80 with symptomatic benign prostatic hyperplasia who were seen in Veterans Affairs outpatient clinics were enrolled. This was a four-armed,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics